Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BioSniper serves as a research platform tailored for equity analysts, investors, and professionals in the life sciences sector. Users can articulate their research or investment ideas in straightforward language, and the platform then organizes this input into a systematic workflow that includes various screenings, checks by specialized agents, scoring mechanisms, blocking protocols, and gates for evidence. It conducts searches across seven categories of public sources, which encompass SEC EDGAR filings along with insider trading data, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. The platform ensures that findings are linked to their source records, with any gaps or discrepancies in evidence flagged as unknown instead of making assumptions; it also provides the source and applicable dates when they are available. Furthermore, BioSniper includes a complimentary public calendar for biotech events, an SEC cash runway calculator, and an open-source toolkit in Python for users to leverage. In addition to these features, the platform aims to enhance the decision-making process for its users by providing comprehensive access to relevant data.
Description
EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.
API Access
Has API
No
API Access
Has API
Yes
Screenshots View All
No images available
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
$39/month
A free plan is available. Researcher costs $39/month, and Analyst costs $79/month. Monthly AI credit allowances are 200, 3,000, and 10,000 for Free, Researcher, and Analyst, respectively; the plans also differ in research and customization features.
Free Trial
No
Free Version
Yes
Pricing Details
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
BioSniper
Founded
2024
Country
United States
Website
biosniper.co
Vendor Details
Company Name
EquiReason
Founded
2026
Country
Turkey
Website
equireason.com